In another report, it was found that 17% of prostate cancer cases with multifocal tumors showed both ERG and SPINK1 overexpression within different regions of either the same tumor focus or different foci, but not in the same tumor cells (Lu et al., 2020). Here, SPINK1 is linked to prostate cancer.